EDGAR Filing Documents for 0001193125-17-230352

Form 8-K - Current report:

SEC Accession No. 0001193125-17-230352

Filing Date

2017-07-18

Accepted

2017-07-18 16:40:03

Documents

Period of Report

2017-07-18

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d425897d8k.htm	8-K	32337
2	EX-99.1	d425897dex991.htm	EX-99.1	7086
3	GRAPHIC	g425897gra.jpg	GRAPHIC	12405
	Complete submission text file	0001193125-17-230352.txt		58227

Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142

Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000

Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)